Search
Descriptor English: Flavoxate
Descriptor Spanish: Flavoxato
Descriptor flavoxato
Scope note: Fármaco que se ha utilizado para tratar diiversos síndromes urinarios y como antiespasmódico. Su utilidad terapéutica y su mecanismo de acción no están claros. Podría tener actividad anestésica y efectos relajantes directos sobre el músculo liso y alguna actividad como antagonista muscarínico.
Descriptor Portuguese: Flavoxato
Descriptor French: Flavoxate
Entry term(s): Chlorhydrate de flavoxate
Tree number(s): D03.383.663.283.266.450.260.444
D03.633.100.150.266.450.260.444
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D005422
Scope note: A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Parasympatholytics
Urological Agents
Registry Number: 3E74Y80MEY
CAS Type 1 Name: 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester
DeCS ID: 5557
Unique ID: D005422
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1976/04/13
Revision Date: 2017/05/24
Flavoxate - Preferred
Concept UI M0008552
Preferred term Flavoxate
Chlorhydrate de flavoxate - Narrower
Concept UI M0008554
Preferred term Chlorhydrate de flavoxate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey